PYXIS ONCOLOGY INC (PYXS) Stock Earnings & Estimates
USA - NASDAQ:PYXS - US7473241013 - Common Stock
3.46 USD
+0.08 (+2.37%)
3.46 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.146M | 2.87M -82.22% | -100.00% | 3.643M | 16.66M 357.32% | 61.36M 268.31% | 149.03M 142.88% | 280.01M 87.89% | 435.11M 55.39% | |||
| EBITDA YoY % growth | -122.77M -77.75% | -80.269M 34.62% | -65.514M 18.38% | -213.422M -225.77% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -123.48M -77.11% | -82.196M 33.43% | -68.496M 16.67% | -91.219M -33.17% | -107.859M -18.24% | -130.067M -20.59% | -151.595M -16.55% | -134.495M 11.28% | -78.143M 41.90% | 13.025M 116.67% | 133.29M 923.34% | |
| Operating Margin | N/A | N/A | -424.23% | -3,178.37% | N/A | -3,570.34% | -909.94% | -219.19% | -52.43% | 4.65% | 30.63% | |
| EPS YoY % growth | -3.62 19.34% | -1.85 48.90% | -0.95 48.65% | -1.31 -37.43% | -1.20 8.26% | -1.32 -10.22% | -1.25 5.61% | -0.95 23.47% | -0.45 52.41% | 0.19 141.57% | 0.91 381.08% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 1.33% | -0.32 -26.48% | -0.34 3.10% | -0.32 -6.25% | -0.35 -0.62% | -0.35 -11.83% | -0.36 -5.26% | -0.35 -8.80% | -0.36 -2.74% | -0.35 1.92% | -0.20 42.86% | -0.08 76.47% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | 2.887M | N/A | 21.542M | 33.13M | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.277M 2.01% | -23.955M -25.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.30 -3.45% | -0.36 | 0.06 | 16.37% |
| Q1 2025 Q2Q % growth | -0.35 -483.33% | -0.30 | -0.05 | -16.71% |
| Q4 2024 Q2Q % growth | -0.25 24.24% | -0.34 | 0.09 | 25.73% |
| Q3 2024 Q2Q % growth | -0.35 37.50% | -0.32 | -0.03 | -9.51% |
| Q2 2024 Q2Q % growth | -0.29 29.27% | -0.33 | 0.04 | 12.33% |
| Q1 2024 Q2Q % growth | -0.06 89.09% | -0.25 | 0.19 | 75.69% |
| Q4 2023 Q2Q % growth | -0.33 67.33% | -0.48 | 0.15 | 31.89% |
| Q3 2023 Q2Q % growth | -0.56 34.12% | -0.52 | -0.04 | -8.36% |
| Q2 2023 Q2Q % growth | -0.41 48.10% | -0.66 | 0.25 | 37.92% |
| Q1 2023 Q2Q % growth | -0.55 43.30% | -0.92 | 0.37 | 39.97% |
| Q4 2022 Q2Q % growth | -1.01 48.99% | -0.95 | -0.06 | -6.56% |
| Q3 2022 Q2Q % growth | -0.85 90.51% | -0.83 | -0.02 | -2.44% |
| Q2 2022 Q2Q % growth | -0.79 | -0.78 | -0.01 | -1.64% |
| Q1 2022 Q2Q % growth | -0.97 | -0.62 | -0.35 | -56.03% |
| Q4 2021 Q2Q % growth | -1.98 | -0.37 | -1.61 | -431.47% |
| Q3 2021 Q2Q % growth | -8.96 | -0.52 | -8.44 | -1,618.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | 16.146M | 4.208M | 11.938M | 283.70% |
| Q4 2023 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q2 2023 Q2Q % growth | 637.5K | -637.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.39% | 0% | 7.02% |
| Revenue | N/A | N/A | -1.03% | N/A |